QUINTESCIENCE Trademark

Trademark Overview

On Monday, July 22, 2024, a trademark application was filed for QUINTESCIENCE with the United States Patent and Trademark Office. The USPTO has given the QUINTESCIENCE trademark a serial number of 98659719. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 2, 2025. This trademark is owned by Evolution Medical Communications, LLC. The QUINTESCIENCE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business management consulting services in the field of business lifecycle management strategies for pharmaceutical companies and medical device companies
quintescience

General Information

Serial Number98659719
Word MarkQUINTESCIENCE
Filing DateMonday, July 22, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 8, 2025

Trademark Statements

Goods and ServicesBusiness management consulting services in the field of business lifecycle management strategies for pharmaceutical companies and medical device companies

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, July 22, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEvolution Medical Communications, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPearl River, NY 10965
Party NameEvolution Medical Communications, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPearl River, NY 10965

Trademark Events

Event DateEvent Description
Monday, July 22, 2024NEW APPLICATION ENTERED
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 3, 2025NON-FINAL ACTION WRITTEN
Monday, February 3, 2025NON-FINAL ACTION E-MAILED
Tuesday, April 15, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 15, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Tuesday, April 15, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 16, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 16, 2025FINAL REFUSAL WRITTEN
Tuesday, May 27, 2025TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, May 27, 2025EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, May 27, 2025JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 27, 2025EX PARTE APPEAL-INSTITUTED
Wednesday, June 4, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 4, 2025ASSIGNED TO LIE
Wednesday, April 16, 2025FINAL REFUSAL E-MAILED
Wednesday, June 4, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 9, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 9, 2025EXPARTE APPEAL TERMINATED
Tuesday, July 8, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 8, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 2, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 2, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

quintescience business management companies device pharmaceutical medical lifecycle consulting services field